Literature DB >> 17723621

Differentiation of herbs linked to "Chinese herb nephropathy" from the liquid chromatographic determination of aristolochic acids.

Wan Chan1, Ka Man Hui, Wing Tat Poon, Kim Chung Lee, Zongwei Cai.   

Abstract

A HPLC method was developed and applied to analyze aristolochic acids (AA-I and AA-II) in Chinese medicinal herbs. The herb samples were extracted by using ultrasonication with the extraction efficiency of better than 82%. Extracts were then filtered and injected onto a C18 column eluting under a gradient program using methanol and water-containing 0.5% acetic acid. The method with the detection limits of 1.33 ng for AA-I and 7.29 ng for AA-II per injection was successfully applied for the analysis of traditional Chinese medicine (TCM) and related products and differentiation of Chinese medicinal herbs that have previously been misused and caused toxicological effects. The developed protocol provided an example that analysis of selected component markers could serve for health security and quality control of TCM consumption.

Entities:  

Year:  2006        PMID: 17723621     DOI: 10.1016/j.aca.2006.03.008

Source DB:  PubMed          Journal:  Anal Chim Acta        ISSN: 0003-2670            Impact factor:   6.558


  6 in total

1.  Comparative study of the contents of analogues of aristolochic acid in two kinds of Aristolochiae Fructus by high-performance liquid chromatography.

Authors:  Yu-Qiong Xu; Xiao-Wei Li; Guang-Xue Liu; Xuan Wang; Ming-Ying Shang; Xiao-Mei Li; Shao-Qing Cai
Journal:  J Nat Med       Date:  2012-04-08       Impact factor: 2.343

2.  Biomonitoring of aristolactam-DNA adducts in human tissues using ultra-performance liquid chromatography/ion-trap mass spectrometry.

Authors:  Byeong Hwa Yun; Thomas A Rosenquist; Viktoriya Sidorenko; Charles R Iden; Chung-Hsin Chen; Yeong-Shiau Pu; Radha Bonala; Francis Johnson; Kathleen G Dickman; Arthur P Grollman; Robert J Turesky
Journal:  Chem Res Toxicol       Date:  2012-05-04       Impact factor: 3.739

3.  New Approaches for Biomonitoring Exposure to the Human Carcinogen Aristolochic Acid.

Authors:  Byeong Hwa Yun; Viktoriya S Sidorenko; Thomas A Rosenquist; Kathleen G Dickman; Arthur P Grollman; Robert J Turesky
Journal:  Toxicol Res (Camb)       Date:  2015-07-01       Impact factor: 3.524

Review 4.  Risk assessment of upper tract urothelial carcinoma related to aristolochic acid.

Authors:  Felicia Wu; Tianxiu Wang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-03-05       Impact factor: 4.254

5.  Medicinally Used Asarum Species: High-Resolution LC-MS Analysis of Aristolochic Acid Analogs and In vitro Toxicity Screening in HK-2 Cells.

Authors:  Johanna Michl; Olusheyi Bello; Geoffrey C Kite; Monique S J Simmonds; Michael Heinrich
Journal:  Front Pharmacol       Date:  2017-05-22       Impact factor: 5.810

6.  Aristolochic acid-associated urinary tract cancers: an updated meta-analysis of risk and oncologic outcomes after surgery and systematic review of molecular alterations observed in human studies.

Authors:  Yu-Chan Kang; Ming-Hong Chen; Chung-Ying Lin; Chih-Yun Lin; Yen-Ta Chen
Journal:  Ther Adv Drug Saf       Date:  2021-03-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.